InfuSystem Holdings, Inc. (NYSE:INFU - Get Free Report)'s stock price was up 2.6% on Wednesday . The company traded as high as $6.30 and last traded at $6.29. Approximately 70,000 shares changed hands during trading, a decline of 40% from the average daily volume of 116,204 shares. The stock had previously closed at $6.13.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently weighed in on INFU shares. Wall Street Zen cut shares of InfuSystem from a "strong-buy" rating to a "buy" rating in a research note on Wednesday, May 14th. B. Riley upgraded shares of InfuSystem to a "strong-buy" rating in a research report on Thursday, May 8th. Finally, Sidoti upgraded shares of InfuSystem to a "strong-buy" rating in a research report on Tuesday, March 18th.
View Our Latest Report on INFU
InfuSystem Stock Down 6.3%
The firm has a market capitalization of $121.89 million, a PE ratio of 96.68 and a beta of 1.81. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98. The firm's 50-day moving average is $5.91 and its 200 day moving average is $6.43.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. BNP Paribas Financial Markets increased its stake in shares of InfuSystem by 67.9% during the 4th quarter. BNP Paribas Financial Markets now owns 6,844 shares of the company's stock valued at $58,000 after acquiring an additional 2,768 shares during the last quarter. Jump Financial LLC acquired a new position in shares of InfuSystem during the 1st quarter valued at about $58,000. Wells Fargo & Company MN increased its stake in shares of InfuSystem by 51.7% during the 4th quarter. Wells Fargo & Company MN now owns 9,286 shares of the company's stock valued at $78,000 after acquiring an additional 3,165 shares during the last quarter. Summit Global Investments acquired a new position in shares of InfuSystem during the 4th quarter valued at about $86,000. Finally, Virtu Financial LLC acquired a new position in shares of InfuSystem during the 1st quarter valued at about $86,000. 71.13% of the stock is currently owned by hedge funds and other institutional investors.
About InfuSystem
(
Get Free Report)
InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
See Also
Before you consider InfuSystem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InfuSystem wasn't on the list.
While InfuSystem currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
